Medicinal Products

Tadomon 250 mg tablete s produljenim oslobađanjem

Name Tadomon 250 mg tablete s produljenim oslobađanjem
Former Name Tapentadol Laboratorios Liconsa 250 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-239998607
Active Substance tapentadoltartarat
Composition jedna tableta s produljenim oslobađanjem sadrži 250 mg tapentadola (u obliku tapentadoltartarata)
Pharmaceutical Form Tableta s produljenim oslobađanjem
Manufacturer Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska
G.L. Pharma GmbH, Lannach, Austrija
Marketing Authorisation Holder G.L. Pharma GmbH, Schlossplatz 1, Lannach, Austrija
Marketing Authorisation Date 22.03.2024
MA Period of Validity 07.07.2027
Classification Number UP/I-530-09/21-01/71
Registration Number 381-12-01/70-24-11
Prescription Medicinal product subject to medical prescription
Type of prescription poseban recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N02AX06
SmPC download
PL download
Public Assessment Report download

Packaging

Back